Shares in Cizzle Biotechnology Holdings (LSE:CIZ) fell sharply on 15 October 2026 after the company released an announcement titled "Update on Launch of Lung Cancer Test in USA" at 07:00. The announcement, flagged as containing inside information, said that its North American licensee, Cizzle …
The renewed interest in Provexis (LSE:PXS) appears to stem from the sales guidance in its final results for the year to 31 March 2026, published on 30 September 2026. In that announcement, the company said it expects to report sales for the six months …
HUTCHMED (China) Limited (LSE:HCM), the oncology and immunology group quoted on AIM, Nasdaq and the Hong Kong Stock Exchange, is due to unveil detailed data from its SAFFRON global Phase III trial on Sunday 25 October 2026. According to the company's "Data to be …
Verici Dx plc (LSE:VRCI), the AIM-quoted developer of RNA-based diagnostic tests for kidney transplant patients, will hold its General Meeting at 11:30 a.m. on 27 October 2026 at Shoosmiths LLP, 1 Bow Churchyard, London, EC4M 9DQ. The meeting will seek approval of the authority …
In an announcement released at 07:00 on 15 October 2026, Syncona said OMass Therapeutics had closed a $310 million (about £230 million) Series C financing. Syncona committed $10.1 million (about £7.5 million) alongside a global syndicate of investors.
At 07:00 on 15 October 2026, 4basebio announced "its intention to raise gross proceeds of not less than £15 million". The issue price of 515p is an 8.4% discount to the closing price of 562.5p on 14 October 2026, according to the announcement.
Hikma Pharmaceuticals, the London-listed maker of generic, branded and injectable medicines, has an unusually busy investor calendar over the coming weeks. The group will host the first of three educational seminars on its R&D strategy on 20 October, followed by its scheduled trading update …
Its oral health, vitamins and pain-relief franchises expose it to consumer spending and product innovation.
Worldwide Healthcare Trust PLC (LSE:WWH) is a leading London-listed closed-ended investment trust dedicated to investing in the global healthcare and biotechnology sectors, holding an established position within the FTSE 250 index. Managed by specialized global healthcare investment firm OrbiMed Capital, the trust provides public …
Optima Health plc (LSE:OPT) has achieved transformative operational scale, establishing itself as the undisputed market leader in United Kingdom occupational health and employee clinical wellbeing services following its landmark admission to the London Stock Exchange's AIM market. The healthcare services group provides corporate occupational …